Teams link: Join the meeting now

Meeting ID: 277 080 580 861 9

Passcode: nk3a6S6b

Learning Objectives: 

  • Analyze pharmacokinetic and pharmacodynamic modeling data to differentiate dalbavancin dosing strategies​
  • Evaluate the outcomes of the DOTS trial and its clinical implications​
  • Identify populations most likely to benefit from dalbavancin therapy and implementation of UW Health antimicrobial stewardship protocols
Session date: 
03/19/2026 - 2:00pm to 3:00pm CDT
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
See map: Google Maps
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Cate Christopherson, PharmD